X-78273725-T-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_006639.4(CYSLTR1):ā€‹c.22A>Gā€‹(p.Thr8Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000148 in 1,084,286 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 23)
Exomes š‘“: 0.000015 ( 0 hom. 5 hem. )

Consequence

CYSLTR1
NM_006639.4 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.76
Variant links:
Genes affected
CYSLTR1 (HGNC:17451): (cysteinyl leukotriene receptor 1) This gene encodes a member of the G-protein coupled receptor 1 family. The encoded protein is a receptor for cysteinyl leukotrienes, and is involved in mediating bronchoconstriction via activation of a phosphatidylinositol-calcium second messenger system. Activation of the encoded receptor results in contraction and proliferation of bronchial smooth muscle cells, eosinophil migration, and damage to the mucus layer in the lung. Upregulation of this gene is associated with asthma and dysregulation may also be implicated in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21456128).
BS2
High Hemizygotes in GnomAdExome4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CYSLTR1NM_006639.4 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 3/3 ENST00000373304.4 NP_006630.1 Q9Y271Q38Q91Q38Q88
CYSLTR1NM_001282186.2 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 2/2 NP_001269115.1 Q9Y271Q38Q91Q38Q88
CYSLTR1NM_001282187.2 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 4/4 NP_001269116.1 Q9Y271Q38Q91Q38Q88
CYSLTR1NM_001282188.2 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 4/4 NP_001269117.1 Q9Y271Q38Q91Q38Q88

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CYSLTR1ENST00000373304.4 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 3/31 NM_006639.4 ENSP00000362401.3 Q9Y271
CYSLTR1ENST00000614798.1 linkuse as main transcriptc.22A>G p.Thr8Ala missense_variant 2/21 ENSP00000478492.1 Q9Y271

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD3 exomes
AF:
0.00000573
AC:
1
AN:
174495
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
60595
show subpopulations
Gnomad AFR exome
AF:
0.0000769
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000148
AC:
16
AN:
1084286
Hom.:
0
Cov.:
32
AF XY:
0.0000142
AC XY:
5
AN XY:
352570
show subpopulations
Gnomad4 AFR exome
AF:
0.0000383
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000334
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000168
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
23
Bravo
AF:
0.0000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 31, 2024The c.22A>G (p.T8A) alteration is located in exon 3 (coding exon 1) of the CYSLTR1 gene. This alteration results from a A to G substitution at nucleotide position 22, causing the threonine (T) at amino acid position 8 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
16
DANN
Benign
0.87
DEOGEN2
Benign
0.20
T;T
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.43
.;T
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.21
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.69
N;N
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.1
N;.
REVEL
Benign
0.11
Sift
Benign
0.064
T;.
Sift4G
Benign
0.14
T;T
Polyphen
0.87
P;P
Vest4
0.18
MutPred
0.23
Gain of loop (P = 0.1081);Gain of loop (P = 0.1081);
MVP
0.86
MPC
0.015
ClinPred
0.089
T
GERP RS
4.5
Varity_R
0.12
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760115491; hg19: chrX-77529222; API